(Q73147184)

English

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model

scientific article published on 01 November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

author name string

P A Davol

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Garza

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A R Frackelton

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

86

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1733-1741

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Biologic therapy of melanoma with cytokines and lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Interactions of melanocytes and melanoma cells with the microenvironment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan Polysulfate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin binds to platelet-derived growth factor and inhibits its biological activity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin, an active drug for prostate cancer: interim observations in a phase I trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Effects of suramin on in vitro growth of fresh human tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin-induced skin reactions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Acute renal toxicity associated with suramin in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Targeting DNA to cells with basic fibroblast growth factor (FGF2).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin: an anticancer drug with a unique mechanism of action.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Effect of the lysosomotropic drug suramin on islet lysosomal enzyme activities and the insulin-secretory response induced by various secretagogues

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1733%3A%3AAID-CNCR15%3E3.0.CO%3B2-H

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991101)86:9<1733::AID-CNCR15>3.0.CO;2-H

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547546%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73147184&oldid=1742473893"